What Bowel Symptoms Suggest IBD with Pyoderma Gangrenosum?
At a Glance
People with pyoderma gangrenosum should report persistent diarrhea, urgency, blood or mucus in stool, abdominal pain, changes around the anus, weight loss, fever, or fatigue because these may signal inflammatory bowel disease. Severe bleeding or pain needs urgent care.
In this answer
4 sections
It is important for anyone diagnosed with pyoderma gangrenosum (PG) to monitor their digestive health. PG is associated with inflammatory bowel disease (IBD)—such as Crohn’s disease or ulcerative colitis—with a meta-analysis estimating that about 17.6% of people with PG also have IBD [1]. However, most people with PG will not necessarily develop IBD. Since early detection can improve your care, being aware of which bowel symptoms to report can help you and your doctor decide if further evaluation is needed [2][3].
When to Seek Urgent Medical Care
Not all digestive symptoms require a trip to the emergency room, but some signs indicate a potential emergency. Seek immediate medical attention if you experience:
- Heavy or ongoing rectal bleeding, or black, tarry stools (which can be a sign of internal bleeding)
- Severe, sudden, or worsening abdominal pain
- Fainting, severe dizziness, or confusion
- Persistent vomiting or an inability to keep fluids down
- A painful swelling around your anus, especially if accompanied by a fever or pus (which could be an abscess)
Key Bowel Symptoms to Discuss with Your Care Team
Many common issues, like infections, dietary changes, or certain medications, can cause temporary stomach upset. However, you should contact your care team soon if you notice persistent or unexplained changes, as these can be clues for underlying IBD:
- Changes in Bowel Habits: Persistent or recurrent diarrhea, an urgent need to have a bowel movement, or frequently waking up during the night to use the bathroom [2].
- Blood or Mucus: Seeing bright red blood or mucus in your bowel movements [2]. Note that while this can be a sign of IBD, it can also be caused by hemorrhoids or infections.
- Abdominal Discomfort: Ongoing abdominal pain or cramping [2].
- Perianal Issues: Draining openings (fistulae), fissures, or new skin tags around the anus [4][5]. While these can be caused by other conditions like hemorrhoids or hidradenitis, they are particularly relevant clues for Crohn’s disease [5].
- Systemic Signs: Unexplained weight loss, fever, or extreme fatigue [2]. Your doctor may also detect anemia (a low red blood cell count) through routine blood work, which can sometimes accompany IBD [6][7].
Tip: Keep a symptom log noting how often you have bowel movements, what they look like, and any pain, fever, or medication use to share with your doctor.
Do Skin and Bowel Symptoms Flare Together?
It is a common misconception that your skin and your bowel will always flare at the same time. While they often do—for example, one specific study of PG patients with IBD found that 93% of them had active bowel disease at the time their PG was diagnosed—this is not universally true for everyone [8].
Sometimes, PG skin ulcers worsen while IBD is completely quiet or in remission [9][8]. In other cases, the skin lesions appear before a formal IBD diagnosis is made [10]. In fact, mild or completely absent bowel symptoms do not entirely rule out IBD; doctors have occasionally discovered underlying colitis in PG patients who had no noticeable digestive complaints [11][3]. However, this does not mean every person with PG needs invasive testing if they have no bowel symptoms.
Getting Evaluated
Because of the link between these conditions, your dermatologist or primary care doctor may recommend a referral to a gastroenterologist (a doctor specializing in the digestive system) [12]. A referral does not automatically mean you will need a colonoscopy; it simply means an expert can help determine if testing is appropriate based on your symptoms, family history, and risk factors.
If your doctor suspects IBD or wants to rule out other causes (like infections), they may start with non-invasive testing:
- Blood tests: To check for anemia, white blood cell counts, and inflammatory markers like CRP or ESR [13][6]. Keep in mind that these markers can sometimes be normal even if you have IBD.
- Stool tests: To rule out bacterial infections and measure fecal calprotectin (a marker of inflammation in the intestines) [14][15]. Elevated calprotectin suggests inflammation, but it is not specific to IBD and can also rise due to infections or certain pain relievers (NSAIDs).
While these initial tests provide helpful clues, they cannot confirm IBD on their own. If your symptoms or test results raise suspicion, a gastroenterologist may recommend an endoscopy/colonoscopy [16] or imaging (like an MRI or CT scan) [11]. A colonoscopy allows the doctor to look directly at the lining of your colon and take small tissue samples (biopsies). While a colonoscopy often provides critical diagnostic evidence, it may not see isolated inflammation higher up in the small intestine, which is why imaging is sometimes needed as well [17][16].
(Note: Never stop taking your PG medications without speaking to your doctor, even if you are concerned they might be masking bowel symptoms).
Common questions in this guide
What bowel changes can suggest IBD in someone with pyoderma gangrenosum?
Does having pyoderma gangrenosum mean I will develop inflammatory bowel disease?
Can bowel disease and pyoderma gangrenosum flare at different times?
What tests might check for IBD after bowel symptoms develop?
When are digestive symptoms with pyoderma gangrenosum an emergency?
Should I stop my pyoderma gangrenosum medicine if I am worried about bowel symptoms?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I develop new bowel symptoms like diarrhea or abdominal pain, what is the best way to contact you, and what signs mean I should go to the emergency room?
- 2.Should I be referred to a gastroenterologist to discuss my risk for IBD, even if I currently have no bowel symptoms?
- 3.Could any of my current medications, or a recent infection, explain the digestive symptoms I am having?
- 4.What specific symptoms or test results would lead you to recommend a colonoscopy or imaging?
- 5.Are my current medications for my skin lesions likely to mask symptoms of underlying bowel inflammation, and how does that affect my monitoring?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.
Kridin K, Cohen AD, Amber KT
American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.
PMID: 29721816 - 2
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review.
Garieri P, Marcasciano M, Greto Ciriaco A, et al.
European review for medical and pharmacological sciences 2022; (26(14)):5191-5199 doi:10.26355/eurrev_202207_29308.
PMID: 35916817 - 3
Ulcerative Colitis Diagnosed through Evaluation of Underlying Diseases in a Pyoderma Gangrenosum Adolescent without Gastrointestinal Symptoms.
Kwon IJ, Park JW, Park S, et al.
Annals of dermatology 2023; (35(Suppl 2)):S292-S295 doi:10.5021/ad.22.101.
PMID: 38061724 - 4
[Healing of severe morbus Crohn-related pyoderma gangrenosum after colectomy].
Henneberg J, Heidenheim M, Munck LK
Ugeskrift for laeger 2021; (183(11)).
PMID: 33734075 - 5
Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
Afarideh M, Bartoletta K, Tollefson MM
Pediatric dermatology 2024; (41(2)):234-242 doi:10.1111/pde.15538.
PMID: 38326222 - 6
[Ulcerative colitis diagnosed with facial pyoderma gangrenosum: a case report].
Ogata Y, Soeda A, Saura I, et al.
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2024; (121(6)):481-488 doi:10.11405/nisshoshi.121.481.
PMID: 38853017 - 7
Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum.
Jiang YY, Li J, Li Y, et al.
Chinese medical journal 2017; (130(22)):2674-2679 doi:10.4103/0366-6999.218004.
PMID: 29133754 - 8
Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis.
Chen W, Xiang L, Li L
Indian journal of dermatology 2020; (65(1)):38-41 doi:10.4103/ijd.IJD_505_18.
PMID: 32029938 - 9
Pyoderma Gangrenosum of the Preauricular Area with Ulcerative Colitis: A Case Report and Review.
Chae HS, Han SM, Lee HN, et al.
Journal of audiology & otology 2018; (22(4)):248-252 doi:10.7874/jao.2018.00171.
PMID: 29890815 - 10
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS, Torre AC, Bollea-Garlatti ML, et al.
International journal of dermatology 2017; (56(4)):386-391 doi:10.1111/ijd.13591.
PMID: 28295267 - 11
Pyoderma Gangrenosum as the First Manifestation of Inflammatory Bowel Disease: A Case Report.
Nguyen NH, Tran TT, Khuc TT, et al.
Case reports in gastrointestinal medicine 2026; (2026()):2028354 doi:10.1155/crgm/2028354.
PMID: 41536753 - 12
Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.
Guillo L, D'Amico F, Serrero M, et al.
United European gastroenterology journal 2020; (8(9)):1013-1030 doi:10.1177/2050640620950093.
PMID: 32778004 - 13
[Fecal calprotectin as a diagnostic marker of inflammatory bowel disease].
Kostrzewska P, Całkosiński A, Majewski M, Malinowski K
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2022; (50(295)):58-61.
PMID: 35278302 - 14
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.
Dajti E, Frazzoni L, Iascone V, et al.
Alimentary pharmacology & therapeutics 2023; (58(11-12)):1120-1131 doi:10.1111/apt.17754.
PMID: 37823411 - 15
[Calprotectin-a key for diagnosing chronic inflammatory bowel disease in inflammatory dermatoses? : Three case reports].
Koutra E, Lusmöller E, Stadler R
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2022; (73(4)):303-307 doi:10.1007/s00105-021-04821-5.
PMID: 33884437 - 16
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Peyrin-Biroulet L, Sandborn W, Sands BE, et al.
The American journal of gastroenterology 2015; (110(9)):1324-38 doi:10.1038/ajg.2015.233.
PMID: 26303131 - 17
Faecal calprotectin in dermatology practice.
Premjeyanth V, Shipman AR, Shipman KE
Clinical and experimental dermatology 2020; (45(7)):831-835 doi:10.1111/ced.14307.
PMID: 32578256
This page explains which bowel symptoms may warrant evaluation for inflammatory bowel disease in someone with pyoderma gangrenosum for informational purposes only and does not constitute medical advice. Discuss your symptoms and medication decisions with your healthcare team.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.